Cas no 175868-01-6 (tert-butyl N-{3-azabicyclo[3.1.1]heptan-1-yl}carbamate)
tert-butyl N-{3-azabicyclo[3.1.1]heptan-1-yl}carbamate Chemical and Physical Properties
Names and Identifiers
-
- Carbamic acid,3-azabicyclo[3.1.1]hept-1-yl-, 1,1-dimethylethyl ester (9CI)
- Carbamic acid, 3-azabicyclo[3.1.1]hept-1-yl-, 1,1-dimethylethyl ester (9CI)
- tert-butyl N-{3-azabicyclo[3.1.1]heptan-1-yl}carbamate
- CS-0434056
- tert-Butyl 3-azabicyclo[3.1.1]heptan-1-ylcarbamate
- tert-butyl N-(3-azabicyclo[3.1.1]heptan-1-yl)carbamate
- MFCD28955414
- SCHEMBL20940142
- tert-Butyl3-azabicyclo[3.1.1]heptan-1-ylcarbamate
- PS-17697
- E79996
- tert-Butyl-3-aZabicyclo[3.1.1]heptan-1-ylcarbamate
- 175868-01-6
- 1-(Boc-amino)-3-azabicyclo[3.1.1]heptane
-
- MDL: MFCD28955414
- Inchi: 1S/C11H20N2O2/c1-10(2,3)15-9(14)13-11-4-8(5-11)6-12-7-11/h8,12H,4-7H2,1-3H3,(H,13,14)
- InChI Key: DDCLWQQNPIZBNG-UHFFFAOYSA-N
- SMILES: O(C(C)(C)C)C(NC12CNCC(C1)C2)=O
Computed Properties
- Exact Mass: 212.1526
- Monoisotopic Mass: 212.152477885g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 15
- Rotatable Bond Count: 3
- Complexity: 264
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.9
- Topological Polar Surface Area: 50.4?2
Experimental Properties
- PSA: 50.36
tert-butyl N-{3-azabicyclo[3.1.1]heptan-1-yl}carbamate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Ambeed | A761895-5g |
tert-Butyl 3-azabicyclo[3.1.1]heptan-1-ylcarbamate |
175868-01-6 | 97% | 5g |
$4243.0 | 2024-04-22 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBSQ600064-100mg |
tert-butyl N-{3-azabicyclo[3.1.1]heptan-1-yl}carbamate |
175868-01-6 | 97% | 100mg |
¥2046.0 | 2024-04-23 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBSQ600064-250mg |
tert-butyl N-{3-azabicyclo[3.1.1]heptan-1-yl}carbamate |
175868-01-6 | 97% | 250mg |
¥3279.0 | 2024-04-23 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBSQ600064-500mg |
tert-butyl N-{3-azabicyclo[3.1.1]heptan-1-yl}carbamate |
175868-01-6 | 97% | 500mg |
¥5465.0 | 2024-04-23 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBSQ600064-1g |
tert-butyl N-{3-azabicyclo[3.1.1]heptan-1-yl}carbamate |
175868-01-6 | 97% | 1g |
¥8196.0 | 2024-04-23 | |
| Chemenu | CM510939-250mg |
tert-Butyl3-azabicyclo[3.1.1]heptan-1-ylcarbamate |
175868-01-6 | 97% | 250mg |
$1359 | 2022-12-31 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBSQ600064-100.0mg |
tert-butyl N-{3-azabicyclo[3.1.1]heptan-1-yl}carbamate |
175868-01-6 | 97% | 100.0mg |
¥2046.0000 | 2025-04-12 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBSQ600064-250.0mg |
tert-butyl N-{3-azabicyclo[3.1.1]heptan-1-yl}carbamate |
175868-01-6 | 97% | 250.0mg |
¥3279.0000 | 2025-04-12 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBSQ600064-500.0mg |
tert-butyl N-{3-azabicyclo[3.1.1]heptan-1-yl}carbamate |
175868-01-6 | 97% | 500.0mg |
¥5465.0000 | 2025-04-12 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBSQ600064-1.0g |
tert-butyl N-{3-azabicyclo[3.1.1]heptan-1-yl}carbamate |
175868-01-6 | 97% | 1.0g |
¥8196.0000 | 2025-04-12 |
tert-butyl N-{3-azabicyclo[3.1.1]heptan-1-yl}carbamate Related Literature
-
2. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
-
Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
-
Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
Additional information on tert-butyl N-{3-azabicyclo[3.1.1]heptan-1-yl}carbamate
Comprehensive Overview of tert-butyl N-{3-azabicyclo[3.1.1]heptan-1-yl}carbamate (CAS No. 175868-01-6)
tert-butyl N-{3-azabicyclo[3.1.1]heptan-1-yl}carbamate (CAS No. 175868-01-6) is a specialized organic compound widely utilized in pharmaceutical research and fine chemical synthesis. This compound belongs to the class of carbamate-protected amines, which are pivotal intermediates in the development of bioactive molecules. Its unique 3-azabicyclo[3.1.1]heptane scaffold makes it a valuable building block for drug discovery, particularly in targeting neurological and metabolic disorders.
The growing interest in tert-butyl N-{3-azabicyclo[3.1.1]heptan-1-yl}carbamate is driven by its role in peptide coupling reactions and protecting group strategies. Researchers frequently search for "carbamate protecting group stability" or "azabicycloheptane derivatives in drug design," reflecting its relevance in modern medicinal chemistry. The compound's stability under acidic conditions and compatibility with solid-phase peptide synthesis (SPPS) further enhance its appeal.
Recent advancements in AI-driven drug discovery have spotlighted compounds like 175868-01-6 due to their structural diversity. Searches for "scaffold hopping in lead optimization" or "small molecule libraries for high-throughput screening" often include references to such bicyclic amines. The tert-butyloxycarbonyl (Boc) group in this molecule ensures efficient deprotection, a feature highly valued in combinatorial chemistry.
From a synthetic perspective, tert-butyl N-{3-azabicyclo[3.1.1]heptan-1-yl}carbamate is synthesized via nucleophilic substitution or carbamate formation protocols. Its crystalline form and high purity (>98%) make it suitable for X-ray crystallography studies, addressing queries like "how to characterize azabicyclo compounds." The compound's logP value and hydrogen bonding capacity are also critical parameters for pharmacokinetic modeling.
Environmental and regulatory considerations are increasingly shaping compound selection. 175868-01-6 aligns with green chemistry principles, as evidenced by searches for "sustainable amine protection methods." Its minimal ecological footprint and compatibility with biodegradable solvents position it favorably in ESG-compliant research initiatives.
In conclusion, tert-butyl N-{3-azabicyclo[3.1.1]heptan-1-yl}carbamate exemplifies the intersection of structural innovation and practical utility in organic synthesis. Its applications span from neuropharmaceuticals to catalysis research, making it a compound of enduring scientific interest. Ongoing studies exploring its stereoselective reactions and bioisosteric potential continue to expand its industrial relevance.
175868-01-6 (tert-butyl N-{3-azabicyclo[3.1.1]heptan-1-yl}carbamate) Related Products
- 488728-06-9(tert-butyl N-[(3S,4S)-4-ethyl-3-piperidyl]carbamate)
- 134575-47-6(tert-butyl N-{3-azabicyclo[4.1.0]heptan-1-yl}carbamate)
- 1169762-18-8(tert-butyl N-[(3R)-3-methylpiperidin-3-yl]carbamate)
- 488728-05-8(tert-butyl N-[(3S,4R)-4-ethyl-3-piperidyl]carbamate)
- 454709-84-3(tert-butyl N-(4-methylpiperidin-3-yl)carbamate)
- 1203651-07-3(tert-butyl N-[(3S,5R)-5-methylpiperidin-3-yl]carbamate)
- 1363378-21-5(tert-butyl N-[(3S)-3-methylpiperidin-3-yl]carbamate)
- 1250997-46-6(tert-butyl N-({2-azabicyclo[2.1.1]hexan-1-yl}methyl)carbamate)
- 951163-61-4(tert-butyl N-[(3S,5S)-5-methylpiperidin-3-yl]carbamate)
- 169750-96-3(tert-butyl n-(3-methylpiperidin-3-yl)carbamate)